|
MRFAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.03170813506404E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.16260000410296E-08 |
| Normal-vs-Stage2 |
2.11020001472662E-09 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.92346139016308E-12 |
| Stage1-vs-Stage2 |
1.977590E-02 |
| Stage1-vs-Stage3 |
1.19259999986632E-07 |
| Stage1-vs-Stage4 |
6.13039999999287E-05 |
| Stage2-vs-Stage3 |
1.303200E-01 |
| Stage2-vs-Stage4 |
3.054600E-01 |
| Stage3-vs-Stage4 |
6.238200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62903024403249E-12 |
| Normal-vs-AfricanAmerican |
1.833250E-04 |
| Normal-vs-Asian |
1.623820E-03 |
| Caucasian-vs-AfricanAmerican |
3.585500E-02 |
| Caucasian-vs-Asian |
5.804200E-01 |
| AfricanAmerican-vs-Asian |
2.298400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
5.60609999533668E-08 |
| Male-vs-Female |
2.157400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.13200000000113E-05 |
| Normal-vs-Age(41-60Yrs) |
1.42770240074697E-11 |
| Normal-vs-Age(61-80Yrs) |
1.75648384725946E-12 |
| Normal-vs-Age(81-100Yrs) |
4.35889999994554E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.773600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.554400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.164000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.990800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.440800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.991400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.293800E-01 |
| Normal-vs-Grade 2 |
4.65299999641289E-08 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.63125069008174E-12 |
| Grade 1-vs-Grade 2 |
1.888180E-02 |
| Grade 1-vs-Grade 3 |
5.80759999999625E-05 |
| Grade 1-vs-Grade 4 |
1.7897399999911E-05 |
| Grade 2-vs-Grade 3 |
6.26109999957158E-07 |
| Grade 2-vs-Grade 4 |
4.4866000026289E-08 |
| Grade 3-vs-Grade 4 |
4.944300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.12820000300829E-08 |
| Normal-vs-ccB subtype |
1.62458935193399E-12 |
| ccA subtype-vs-ccB subtype |
4.1121994698301E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.50366394283219E-12 |
| Normal-vs-N1 |
2.69459999979738E-07 |
| N0-vs-N1 |
7.046100E-02 |
|
|
